Neurodegeneration, a continuous decline in the integrity of nerves, presents a daunting challenge to modern medicine. While there is currently no solution for neurodegenerative conditions, researchers are actively exploring innovative therapeutic approaches. One such pathway of research involves deschloroketamine, a analog of the anesthetic ketamin